# The DDI Study of SP2086 and Simvastatin

> **NCT02817243** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** SP2086
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT02817243
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2016-07
- **Final completion:** —
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2016-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02817243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02817243, "The DDI Study of SP2086 and Simvastatin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02817243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*